EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The evolution of preimplantation genetic testing: where is the limit?

Antonio Capalbo, Dagan Wells

Reproductive BioMedicine Online · 2025-04 · 50 (4) · 104845

DOI: 10.1016/j.rbmo.2025.104845 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reproductive BioMedicine Online, 2025-04. Verfasst von Antonio Capalbo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Juno Genetics, via di quarto peperino 22, 00188, Rome, Italy; Unit of Molecular Genetics, Center for Advanced Studies and Technology (CAST), "G. D'An…. Hauptthemen laut MEDLINE: Preimplantation Diagnosis, Genetic Testing. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preimplantation genetic testing (PGT) has revolutionized reproductive medicine over the past 30 years, providing a reliable method for reducing the risk of transmitting severe inherited conditions and offering the possibility of improved IVF outcomes. Today, PGT is widely accepted and integrated into fertility care in many countries around the world. Its history, however, has not been without controversy, with debate around its application to the diagnosis of late-onset disorders, conditions with incomplete penetrance and its use for embryo selection based upon human leukocyte antigen status. Nonetheless, PGT has progressively broadened its scope, and the number of embryos undergoing genetic testing continues to grow each year. Preimplantation genetic testing is most often used for the detection of chromosomal abnormalities, assisting in the identification of embryos affected by lethal aneuploidy. This application has generated the greatest debate of all, owing, in part, to difficulties delivering effective embryo testing using earlier methods. In recent years, advances in technology and rigorous validation studies have helped to improve accuracy, although variability among methods underscores the need for greater standardization and transparency. Emerging technologies, such as whole genome sequencing (WGS) and genome editing, hold promise for further advancements but introduce complex ethical, privacy and consent challenges that demand careful consideration, public engagement and thorough clinical research before implementation. Given its current trajectory, it seems likely that the use of PGT will continue to grow, offering reduced reproductive risks and the possibility of enhanced fertility treatment outcomes for ever greater numbers of patients, ultimately becoming an accepted cornerstone of reproductive care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Preimplantation DiagnosisGenetic TestingHumansFemalePregnancy

Stichwörter der Autor:innen

AneuploidiesFertilityIVFMonogenic diseasesPreimplantation genetic testing (PGT)Whole genome seqeuencing

Autor:innen und Institutionen

  • Juno Genetics, via di quarto peperino 22, 00188, Rome, Italy; Unit of Molecular Genetics, Center for Advanced Studies and Technology (CAST), "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy; IVI Foundation, H…
  • Juno Genetics, Hayakawa Building, Oxford Science Park, Oxford, OX4 4GB, UK; University of Oxford, Nuffield Department of Women's and Reproductive Health, John Radcliffe Hospital, Oxford, OX3 9DU, UK. Electronic address:…

Zitieren

APA

Capalbo, A., & Wells, D. (2025). The evolution of preimplantation genetic testing: where is the limit?. Reproductive BioMedicine Online, 50(4), 104845. https://doi.org/10.1016/j.rbmo.2025.104845

Vancouver

Capalbo A, Wells D. The evolution of preimplantation genetic testing: where is the limit?. Reproductive BioMedicine Online. 2025;50(4):104845. doi:10.1016/j.rbmo.2025.104845

BibTeX
@article{Capalbo2025,
  author = {Capalbo, Antonio and Wells, Dagan},
  title = {The evolution of preimplantation genetic testing: where is the limit?},
  journal = {Reproductive BioMedicine Online},
  year = {2025},
  volume = {50},
  number = {4},
  pages = {104845},
  doi = {10.1016/j.rbmo.2025.104845}
}
Kostenlos starten →